Enlaza Therapeutics Raises $61 Million in Seed Round
Enlaza Therapeutics is a company of Enlaza Therapeutics. Its proprietary War-Lock platform utilizes its advanced synthetic biology technology to incorporate non-natural amino acids with expanded chemical functions into protein drugs, enabling the drug to interact with its target site-specifically. One-way covalent bonding. Its proprietary amino acid subunits can bind to almost all forms of proteins […]
Enlaza Therapeutics Raises $61 Million in Seed Round Read More »